Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lemaitre Vascular
(NQ:
LMAT
)
105.80
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
18
Open
105.80
Bid (Size)
42.32 (2)
Ask (Size)
113.13 (1)
Prev. Close
105.80
Today's Range
105.80 - 105.80
52wk Range
51.70 - 109.58
Shares Outstanding
22,263,235
Dividend Yield
0.60%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
November 18, 2024
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth.
Via
Investor's Business Daily
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
November 01, 2024
Via
Benzinga
Performance
YTD
+86.56%
+86.56%
1 Month
+17.02%
+17.02%
3 Month
+19.39%
+19.39%
6 Month
+34.32%
+34.32%
1 Year
+102.18%
+102.18%
More News
Read More
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
November 01, 2024
Via
Benzinga
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 15, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
October 15, 2024
Via
Benzinga
Navigating 4 Analyst Ratings For LeMaitre Vascular
May 31, 2024
Via
Benzinga
Recap: LeMaitre Vascular Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
A Preview Of LeMaitre Vascular's Earnings
February 26, 2024
Via
Benzinga
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024
August 01, 2024
Via
InvestorPlace
Staar Surgical Stock Earns RS Rating Upgrade
June 27, 2024
Via
Investor's Business Daily
Stryker Stock Sees RS Rating Treks Higher To 71
May 29, 2024
Via
Investor's Business Daily
Sell In May And Go Away? – April Dividend Income Report
May 27, 2024
Via
Talk Markets
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
April 30, 2024
Via
Investor's Business Daily
5 Analysts Have This to Say About LeMaitre Vascular
October 23, 2023
Via
Benzinga
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
February 28, 2024
Via
Benzinga
Sidoti Events, LLC's Virtual December Small-Cap Conference
December 05, 2023
Via
ACCESSWIRE
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
September 06, 2023
Via
Benzinga
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
September 01, 2023
Via
The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
August 26, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
August 23, 2023
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
August 03, 2023
Via
Benzinga
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
August 03, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.